We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+15.71%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.92B
AUM Growth
+$466M
Cap. Flow
-$28.9M
Cap. Flow %
-0.49%
Top 10 Hldgs %
26.27%
Holding
163
New
16
Increased
58
Reduced
30
Closed
24

Top Buys

Rank Stock Value
1
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$87.6M
2
GH icon
Guardant Health
GH
+$61.3M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$37.2M
4
TOST icon
Toast
TOST
+$32M
5
LAD icon
Lithia Motors
LAD
+$28.4M

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$71.9M
2
DOCS icon
Doximity
DOCS
+$45M
3
ENPH icon
Enphase Energy
ENPH
+$36M
4
ROP icon
Roper Technologies
ROP
+$31.6M
5
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$31.6M

Sector Composition

Rank Sector Weight
1 Healthcare 43.76%
2 Technology 22.95%
3 Industrials 13.17%
4 Consumer Discretionary 7.97%
5 Utilities 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AURA icon
51
Aura Biosciences
AURA
$735M
$36.3M 0.61%
2,935,519
+409,689
+16% +$4.38M
TOST icon
52
Toast
TOST
$19.1B
$36.2M 0.61%
+1,603,866
New +$32M
APLS
53
DELISTED
Apellis Pharmaceuticals
APLS
$36.2M 0.61%
397,141
-97,859
-20% -$8.44M
INSP icon
54
Inspire Medical Systems
INSP
$1.44B
$35.1M 0.59%
108,220
– –
HASI icon
55
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$34.5M 0.58%
1,378,800
-41,163
-3% -$1.08M
MRNS
56
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$34.5M 0.58%
3,173,197
– –
SNPS icon
57
Synopsys
SNPS
$71.3B
$34.1M 0.58%
78,211
-1,501
-2% -$605K
RPRX icon
58
Royalty Pharma
RPRX
$26.2B
$32M 0.54%
1,039,718
-9,395
-0.9% -$318K
CDW icon
59
CDW
CDW
$18.6B
$31.2M 0.53%
169,795
– –
PRTA icon
60
Prothena Corp
PRTA
$440M
$30.4M 0.51%
445,155
+6,423
+1% +$414K
WDAY icon
61
Workday
WDAY
$39B
$30.2M 0.51%
133,713
+131,537
+6,045% +$26.3M
NARI
62
DELISTED
Inari Medical, Inc. Common Stock
NARI
$29.8M 0.5%
512,914
– –
TRGP icon
63
Targa Resources
TRGP
$57.6B
$29.8M 0.5%
391,769
+78,820
+25% +$5.72M
KLAC icon
64
KLA
KLAC
$236B
$29.4M 0.5%
607,040
+95,450
+19% +$3.99M
WMB icon
65
Williams Companies
WMB
$86.7B
$29.3M 0.5%
898,307
+193,600
+27% +$5.81M
ORLY icon
66
O'Reilly Automotive
ORLY
$72.4B
$29.1M 0.49%
456,630
+270
+0.1% +$16.5K
BPMC
67
DELISTED
Blueprint Medicines
BPMC
$27.7M 0.47%
438,500
– –
PRVA icon
68
Privia Health
PRVA
$3.01B
$26.1M 0.44%
1,000,000
– –
ISRG icon
69
Intuitive Surgical
ISRG
$126B
$25.7M 0.43%
75,058
+29
+0% +$8.77K
SGEN
70
DELISTED
Seagen Inc. Common Stock
SGEN
$25.2M 0.43%
130,971
-148,863
-53% -$29.6M
STE icon
71
Steris
STE
$22.5B
$25.1M 0.42%
111,646
-24,870
-18% -$4.98M
IRTC icon
72
iRhythm Holdings
IRTC
$3.91B
$24.9M 0.42%
239,135
– –
IMGN
73
DELISTED
Immunogen Inc
IMGN
$24.5M 0.41%
+1,300,000
New +$15.3M
SHW icon
74
Sherwin-Williams
SHW
$83.7B
$24.5M 0.41%
92,105
+27,371
+42% +$6.44M
BEPC icon
75
Brookfield Renewable
BEPC
$6.04B
$24.5M 0.41%
775,851
+448
+0.1% +$15.1K
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Eventide Asset Management held 163 positions worth $5.92B, up 8.6% from $5.45B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management's Q2 2023 filing shows 16 new, 58 increased, 30 reduced and 24 closed positions. Its largest new stake was Toast: 1,603,866 shares worth $36.2M. The largest sale was Prometheus Biosciences, Inc. Common Stock, an estimated $71.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2023 buy was Toast: 1,603,866 shares worth $36.2M.
  • Eventide Asset Management added most to Zentalis Pharmaceuticals in Q2 2023, an estimated $87.6M increase.
  • Eventide Asset Management's biggest Q2 2023 reduction was Doximity, cutting an estimated $45M.
  • Eventide Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $71.9M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $5.92B portfolio in Q2 2023.
  • Eventide Asset Management opened 16 new positions and closed 24 in Q2 2023.
  • Eventide Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.92B.

Based on Eventide Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.